RA Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

RA Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$60.4M	Buy
2021 Q4	$55.9M	Buy
2014 Q2	–	Sell
2014 Q1	$12.5M	Hold
2013 Q4	$10.9M	Buy
2013 Q3	$8.36M	Buy